Bupropion HCL ER

Award NoticeAwarded

This federal contract opportunity has been awarded to on October 6, 2022.

Award Information

This solicitation resulted in an award to for approximately $23,278,524 on October 6, 2022. Similar contracts are typically issued by DEPT OF DEFENSE under 325412 (Pharmaceutical Preparation Manufacturing).

Award Number
SPE2D2-23-D-0002
Award Amount
$23,278,524
Award Date
October 6, 2022

Key Takeaways

  • No response deadline specified - contact the agency for details
  • Full and open competition - all businesses eligible to bid
  • Work to be performed in PHILADELPHIA, PA
  • Industry: Pharmaceutical Preparation Manufacturing

Contract Details

Notice ID
SPE2D2-23-D-0002
Opportunity Type
Award Notice
Sub-Agency
DEFENSE LOGISTICS AGENCY
Office
DLA TROOP SUPPORT
Posted Date
Monday, September 14, 2026
Response Deadline
Not specified
PSC Code
6505
Set-Aside
Full & Open Competition
Place of Performance
PHILADELPHIA, PA, 19111
Status
Active

Description

Modification P00010 SPE2D223D0002 is issued to invoke option year 4 for Bupropion HCL ER National Contract. Modification P00009 SPE2D223D0002 is issued to incorporate clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1) (APR 2026). Modification P00008 SPE2D223D0002 is issued to invoke option year 3 for Bupropion HCL ER National Contract. Modification P00007 SPE2D223D0002 is issued in accordance with DoD Class Deviation 2025-O0003 and Class Deviation 2025-O0004 into subject solicitation. Modification P00006 SPE2D223D0002 is issued to invoke option year 2 for Bupropion HCL ER National Contract. Modification P00005 SPE2D223D0002 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicita

Why This Opportunity Matters

The Department of DEFENSE is seeking responses for pharmaceutical preparation manufacturing in PHILADELPHIA, PA.